Logo (Actavis) 422 (Lamotrigine Extended-Release 100 mg)
Pill with imprint Logo (Actavis) 422 is Gray, Round and has been identified as Lamotrigine Extended-Release 100 mg. It is supplied by Actavis Pharma, Inc..
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 422
Lamotrigine Extended-Release
- Imprint
- Logo (Actavis) 422
- Strength
- 100 mg
- Color
- Gray
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00228-1422
- Inactive Ingredients
-
hypromelloses,
lactose monohydrate,
magnesium stearate,
methacrylic acid - methyl methacrylate copolymer (1:2),
silicon dioxide,
magnesium silicate,
titanium dioxide,
triethyl citrate,
FD&C Blue No. 2,
FD&C Red No. 40,
FD&C Yellow No. 6,
triacetin
Note: Inactive ingredients may vary.
More about lamotrigine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1366 Reviews
- Drug class: triazine anticonvulsants
- FDA Alerts (6)
Consumer resources
- Patient Information
- Lamotrigine (Advanced Reading)
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Tablets
- Other brands
- Lamictal, Lamictal XR, Subvenite, Lamictal ODT, Lamictal CD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.